Candesartan Treatment Associates With Reduced Expression of Collagen and Matrix Metalloproteinase Genes in Severely Stenotic Human Aortic Valves: A Prospective, Placebo-controlled, Randomized, Double-blinded Clinical Trial. (December 2019)